Edward Hurwitz - 30 Aug 2023 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role
Director
Signature
/s/ Lynn M. Cilinski, Attorney-in-fact
Issuer symbol
MGNX
Transactions as of
30 Aug 2023
Net transactions value
+$73,650
Form type
4
Filing time
01 Sep 2023, 16:06:34 UTC
Previous filing
02 Jun 2023
Next filing
22 May 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MGNX Common Stock Purchase $73,650 +15,000 +83% $4.91 33,074 30 Aug 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. This transaction was executed in multiple trades at prices ranging from $4.90 to $4.91. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.